Hoffman Estates, IL – October 10, 2019 – InVia Fertility Specialists announced today it now offers the INVOCELL Intravaginal Culture (IVC) System as part of its scope of reproductive health services. The INVOCELL IVC System, the first-of-its-kind, which comprises the INVOCELL Culture Device and Retention Device,1 is the only IVC system cleared by the Food and Drug Administration.
“We are pleased to add INVOCELL to our current reproductive health offering as an innovative option for patients struggling with infertility,” said Vishvanath Karande, MD. “Statistics show that over 1.4 million women in the United States may benefit from advanced fertility treatment, yet only an estimated 130,000 of them begin such treatment.2 As a cost-conscious option, we believe that INVOCELL will help us improve access to care for those hoping to be parents.”
INVOCELL is a patented medical device used in the treatment of infertility that enables egg fertilization and early embryo development to take place in a woman's body. The eggs are retrieved from a woman’s ovaries and placed in the INVOCELL system with sperm. INVOCELL is then placed in the woman’s body to allow fertilization and incubation to occur, making the patient an even greater part of the process. To learn more, visit www.INVOCELL.com.
INVOCELL Intravaginal Culture System contains the INVOCELL Culture Device and INVOCELL Retention Device. The Culture Device is indicated for use in preparing, holding, and transferring human gametes or embryos during In Vitro Fertilization/Intravaginal Culture (IVF/IVC) and Intra-cytoplasmic Sperm Injection Fertilization/Intravaginal Culture (ICSI/IVC). The Retention Device is used during the incubation period to aid in holding the Culture Device in the vagina. The Culture and Retention Devices are not indicated for periods of use exceeding 72 hours.
Your doctor will determine if this product is right for you and will provide you with more detailed information about the risks and benefits associated with using this device. Always follow your doctor’s instructions. Contact your doctor immediately if you have any questions or concerns before, during, or after treatment.
Please see the INVOCELL Patient Information and Instructions for Use at www.INVOCELL.com.
References:
# # #
For more information, please contact: InVia Fertility Specialists at 847-884-8884
INVO/634/2019/US
INVOCELL is a registered trademark of INVO Bioscience.
Entire Website © 2003 - 2020
Karande and Associates d/b/a InVia
Fertility Specialists